This is a $57,757 firm fixed price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2 to Mckesson Corporation, a for-profit healthcare services and IT company, for the pharmaceutical product LEUKERAN. The award does not utilize any set-aside designations. According to the information provided, Mckesson has a history of serving as a prime contractor for federal healthcare agencies, delivering a range of pharmaceutical products and services...
The Department of Veterans Affairs awarded a firm fixed price purchase order to Mckesson Corporation, valued at $13,884.00, for the emergency procurement of LEUKERAN 2MG pharmaceuticals. This order does not have a set-aside designation and is expected to be completed by June 18, 2024. Mckesson Corporation is a healthcare services and IT company that has provided various pharmaceutical products and services to federal agencies, including the Department of Justice's Bureau of Prisons, the...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 9 to Mckesson Corporation, doing business as Mckesson, for the pharmaceutical product LEUKERAN. The contract has a ceiling value of $14,439.25 and a completion date of April 18, 2025. No set-aside designation was used for this award. Mckesson Corporation is a healthcare services and information technology company that provides pharmaceuticals, medical supplies,...
This is a firm fixed price purchase order awarded to Mckesson Corporation, a healthcare services and information technology company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2. The contract is for the delivery of LEUKERAN, a pharmaceutical product, with a ceiling value of $41,702.00 and a completion date of May 31, 2024. The contract does not have a set-aside designation. Mckesson Corporation is the prime contractor and there is no information provided about...
This federal contract award to Mckesson Corporation, a healthcare services and information technology company, is for the delivery of PHARMACY BUY LEUKERAN products. The contract, valued at $43,317.75, is a firm fixed price purchase order with an ultimate completion date of April 28, 2025. It was awarded on March 28, 2025 by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 19. No set-aside was used for this award. Mckesson Corporation has a history of providing...
This firm fixed price purchase order contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 19 to Mckesson Corporation, a healthcare services and information technology company, for the delivery of LEUKERAN (chlorambucil) 2mg tablets. The contract has a ceiling value of $13,884 and a completion date of November 28, 2024. Mckesson, the prime contractor, has previously held numerous delivery orders and blanket purchase agreements with federal agencies...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 19 (VISN 19), a component of the U.S. Department of Veterans Affairs, to Mckesson Corporation for the delivery of 3 bottles of the pharmaceutical product LEUKERAN (chlorambucil) 2mg tablets. The contract has a ceiling value of $43,317.75 and a period of performance through May 31, 2025. The contract was awarded on May 21, 2025 and does not utilize any set-aside designations. Mckesson Corporation...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 19 to the prime contractor, Mckesson Corporation, for the supply of 25-tablet bottles of the drug Leukeran (chlorambucil) with a ceiling value of $13,884.00. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 2, 2024. No set-aside designation was used. Mckesson Corporation is a healthcare services and information technology...
The Department of Veterans Affairs (VA) awarded a firm fixed price purchase order to Mckesson Corporation, a healthcare services and information technology company, for the delivery of LEUKERAN 2MG 25 TABLET/BOTTLE X4 pharmaceutical products. The contract has a ceiling value of $55,536.00 and a completion date of December 31, 2024. Mckesson has provided a range of pharmaceutical products and services to various federal agencies, including the VA, Department of Health and Human Services' Indian...
McKesson Corporation has been awarded a $55,536 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 for the provision of LEUKERAN pharmaceutical products. The contract has no set-aside designation and deliveries are to be made to an address in Irving, Texas by March 31, 2024. McKesson will serve as the prime contractor, drawing upon its existing capabilities as a major distributor of pharmaceuticals and...